XENT

Intersect ENT Inc.

Price

return (12m)

p/e

-5.51

p/bv

-9.86

DIVIDEND YIELD

0.00%

XENT price

Intersect ENT

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment XENT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals XENT

Valuation

P/E

-5.51

Sector 0.84

Industry -1.42

P/BV

-9.86

Sector 1.82

Industry 1.25

P/Revenue (PSR)

Sector 1.48

Industry 2.13

EV/EBITDA

-38.11

Sector -43.66

Industry -35.45

EV/EBIT

-37.44

Sector -47.57

Industry -38.86

P/EBITDA

-5.58

Sector -31.25

Industry -21.12

P/EBIT

-5.41

Sector -42.58

Industry -25.59

P/Total Assets

7.28

Sector 0.82

Industry 0.70

P/Net Current Assets

Sector -23.77

Industry -59.56

P/Working Capital

Sector -3.73

Industry -1.93

EPS

-5.05

Sector -0.70

Industry -1.22

BVPS

-2.82

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

71.88%

Sector 49.32%

Industry 49.70%

EBITDA Margin

-123.99%

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

-100.00%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-100.00%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.17

Sector 0.13

Industry 0.06

Profitability

ROE

179.10%

Sector -24.30%

Industry -38.97%

ROA

-132.20%

Sector -24.50%

Industry -49.14%

ROIC

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 1.92

Industry 2.55

Net Debt / EBITDA

-3.44

Sector -23.10

Industry -8.80

Net Debt / EBIT

-3.38

Sector -17.84

Industry -36.75

Net Debt / Equity

-0.98

Sector -0.68

Industry -1.16

Gross Debt / Equity

-1.52

Sector -0.72

Industry -0.54

Equity/Assets

-0.74

Sector 0.46

Industry 0.52

Liabilities/Assets

-0.74

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

-0.52%

Sector -

Industry -

5Y Earnings CAGR

1.08%

Sector -

Industry -

Fundamentals XENT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
XENT Intersect ENT Inc.	$0.00	-	0.00%	-5.51	-9.86	179.10%	-100.00%
ABT Abbott Laboratories	$103.75	-16.91%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.84	0.14%	3.02%	23.20	2.39	10.29%	13.93%
BSX Boston Scientific Corp.	$44.56	-55.10%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$72.35	-38.50%	0.00%	16.36	4.79	29.28%	22.69%
RMD ResMed Inc.	$239.43	-9.75%	1.03%	22.76	5.27	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$556.87	-12.36%	0.00%	38.87	27.47	70.67%	25.03%
COHR Coherent Inc.	$240.39	106.61%	0.00%	57.23	4.10	7.16%	11.31%
SYK Stryker Corp.	$298.82	-19.12%	1.18%	30.25	4.70	15.55%	14.43%
PHG Koninklijke Philips NV	$25.60	-6.71%	3.91%	19.13	1.87	9.80%	6.30%
INMD InMode Ltd.	$14.09	-7.97%	0.00%	10.83	1.33	12.32%	20.69%
BDX Becton Dickinson and Company	$190.65	3.33%	2.20%	55.79	2.15	3.85%	6.29%
DXCM DexCom Inc.	$85.63	28.57%	0.00%	33.25	12.68	38.14%	20.12%
EW Edwards Lifesciences Corp.	$86.82	16.32%	0.00%	49.74	4.66	9.37%	15.43%
ALGN Align Technology Inc.	$147.89	13.37%	0.00%	25.13	2.46	9.77%	9.99%
SNN Smith & Nephew PLC	$28.84	-17.84%	2.68%	21.68	4.71	21.74%	9.20%
IRMD iRadimed Corporation	$88.03	21.26%	1.43%	49.39	11.19	22.66%	26.70%
ZBH Zimmer Biomet Holdings Inc.	$94.68	-5.87%	1.02%	22.50	1.44	6.39%	9.48%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XENT - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Intersect ENT

Intersect ENT Inc.

Average Investor10 user rating

4.0 (0 people)

United States

23 years

Founded: 2003

2014

Time since IPO - 12 years

406

Employees

Intersect ENT Inc. (United States) is listed on the Nasdaq and has a market capitalization of $927.52 million, with shareholders equity totaling $-94.03 million.

The company employs approximately 406 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Intersect ENT Inc. reported $104.00 million in revenue, generating net income of $-168.41 million.

Key financial metrics include a P/E ratio of -5.51, a price-to-book (P/B) ratio of -9.86, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker XENT.

Market cap

$927.52 million

Net worth

$-94.03 million

$-94,029,000.00

Assets

$127.39 million

$127,393,000.00

Total Shares Outstanding

33.35 million

33,352,000

Average Daily Trading Volume

$476.83 Thousand

$476,832.58

Sector

Health

Industry

Medical Supplies and Equipment

XENT

XENT revenue and profits

Financial Results XENT

DRAG THE FRAME TO SEE MORE DATA

XENT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76